{"organizations": [], "uuid": "57b531039a49affb7efe484fe62a6009fecf0c7e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.financialexpress.com", "main_image": "http://www.financialexpress.com/wp-content/uploads/2015/03/medicine_reuters_300.jpg", "site_section": "http://www.financialexpress.com/", "section_title": "The Financial Express | India News Today,Latest National News,Stock Market Today,SENSEX NIFTY,NSE BSE India,Finance News,Business News", "url": "http://www.financialexpress.com/article/industry/companies/glenmark-receives-usfda-nod-for-oral-contraceptive-drug/121831", "country": "IE", "title": "Glenmark receives USFDA nod for oral contraceptive drug", "performance_score": 0, "site": "financialexpress.com", "participants_count": 1, "title_full": "Glenmark receives USFDA nod for oral contraceptive drug | The Financial Express", "spam_score": 0.0, "site_type": "news", "published": "2015-08-19T20:00:00.000+03:00", "replies_count": 0, "uuid": "57b531039a49affb7efe484fe62a6009fecf0c7e"}, "author": "financialexpress.com", "url": "http://www.financialexpress.com/article/industry/companies/glenmark-receives-usfda-nod-for-oral-contraceptive-drug/121831", "ord_in_thread": 0, "title": "Glenmark receives USFDA nod for oral contraceptive drug", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Other Articles Uphaar fire tragedy: Rich can get away by paying money, says victim Vedanta Group HR chief Rajesh Padmanabhan resigns Cheating website: Hackers claim to have exposed Ashley Madison users on Web Glenmark Pharmaceuticals today said it has received final approval from the US health regulator to sell oral contraceptive — drospirenone and ethinyl estradiol tablets — in the US market.\n“Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Drospirenone and Ethinyl Estradiol tablets USP, 3 mg/0.02 mg,” the company said in a BSE filing.\nThe product is generic version Bayer’s Yaz tablets.\nGlenmark said it plans to commence shipping of drospirenone and ethinyl Estradiol tablets immediately.\nCiting IMS Health sales data, the company said for the 12 months period ending June, “the Yaz market achieved annual sales of approximately USD 170.1 million”.\nGlenmark’s shares were trading at Rs 1,213.65 apiece, up 4.62 per cent from their previous close on BSE.\n 19, 2015 12:00 pm", "external_links": [], "published": "2015-08-19T20:00:00.000+03:00", "crawled": "2015-08-19T19:21:18.244+03:00", "highlightTitle": ""}